Learn About Acromegaloid Facial Appearance Syndrome
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Murray Gordon is an Endocrinologist in Pittsburgh, Pennsylvania. Dr. Gordon is rated as an Elite provider by MediFind in the treatment of Acromegaloid Facial Appearance Syndrome. His top areas of expertise are Acromegaly, Hypertrichosis-Acromegaloid Facial Appearance Syndrome, Acromegaloid Facial Appearance Syndrome, Hormone Replacement Therapy (HRT), and Thyroidectomy.
Constantine Stratakis is a Medical Genetics specialist and a Gastroenterologist in Bethesda, Maryland. Dr. Stratakis is rated as an Elite provider by MediFind in the treatment of Acromegaloid Facial Appearance Syndrome. His top areas of expertise are Cushing's disease, Neuroendocrine Tumor, Gastrointestinal Stromal Tumor, Orchiectomy, and Hormone Replacement Therapy (HRT).
University Professional Services
Maria Fleseriu is an Endocrinologist in Portland, Oregon. Dr. Fleseriu is rated as an Elite provider by MediFind in the treatment of Acromegaloid Facial Appearance Syndrome. Her top areas of expertise are Acromegaly, Cushing's syndrome, Cushing's disease, Pituitary Tumor, and Hormone Replacement Therapy (HRT).
Summary: There is a variety of tumors affecting the pituitary gland in childhood; some of these tumors (eg craniopharyngioma) are included among the most common central nervous system tumors in childhood. The gene(s) involved in the pathogenesis of these tumors are largely not known; their possible association with other developmental defects or inheritance pattern(s) has not been investigated. The present...
Summary: Acromegaly is a rare chronic disease due to excessive secretion of growth hormone (GH) and insulin-like growth factor-I (IGF-I), caused in over 98% of cases by GH-secreting pituitary adenoma. Prolonged exposure to GH/IGF-I excess is the cause of increased mortality and morbidity in these patients. Arthropathy occurs in about 75% of acromegalic patients. Any joint may be affected, with the developm...